164 related articles for article (PubMed ID: 29458551)
1. Short- and long-term influence of the levonorgestrel-releasing intrauterine system (Mirena®) on vaginal microbiota and Candida.
Donders GGG; Bellen G; Ruban K; Van Bulck B
J Med Microbiol; 2018 Mar; 67(3):308-313. PubMed ID: 29458551
[TBL] [Abstract][Full Text] [Related]
2. Vaginal flora changes on Pap smears after insertion of levonorgestrel-releasing intrauterine device.
Donders GG; Berger J; Heuninckx H; Bellen G; Cornelis A
Contraception; 2011 Apr; 83(4):352-6. PubMed ID: 21397094
[TBL] [Abstract][Full Text] [Related]
3. Reactional changes in short-term levonorgestrel-releasing intrauterine system (lng-ius) use.
Giraldo PC; Souza TC; Henrique GL; Monteiro I; Amaral R; Machado RB; Discacciati MG; Sanches JM
Rev Assoc Med Bras (1992); 2019 Jul; 65(6):857-863. PubMed ID: 31340317
[TBL] [Abstract][Full Text] [Related]
4. Risk of bacterial vaginosis, Trichomonas vaginalis and Candida albicans infection among new users of combined hormonal contraception vs LNG-IUS.
Rezk M; Sayyed T; Masood A; Dawood R
Eur J Contracept Reprod Health Care; 2017 Oct; 22(5):344-348. PubMed ID: 28849960
[TBL] [Abstract][Full Text] [Related]
5. Influence of contraceptive choice on vaginal bacterial and fungal microflora.
Donders G; Bellen G; Janssens D; Van Bulck B; Hinoul P; Verguts J
Eur J Clin Microbiol Infect Dis; 2017 Jan; 36(1):43-48. PubMed ID: 27638008
[TBL] [Abstract][Full Text] [Related]
6. Vaginal microbiome changes with levonorgestrel intrauterine system placement.
Jacobson JC; Turok DK; Dermish AI; Nygaard IE; Settles ML
Contraception; 2014 Aug; 90(2):130-5. PubMed ID: 24835828
[TBL] [Abstract][Full Text] [Related]
7. Effects of intrauterine contraception on the vaginal microbiota.
Bassis CM; Allsworth JE; Wahl HN; Sack DE; Young VB; Bell JD
Contraception; 2017 Sep; 96(3):189-195. PubMed ID: 28624570
[TBL] [Abstract][Full Text] [Related]
8. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF
Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
[TBL] [Abstract][Full Text] [Related]
9. Cytological evaluation and investigation of the vaginal flora of long-term users of the levonorgestrel-releasing intrauterine system (LNG-IUS).
Lessard T; Simões JA; Discacciati MG; Hidalgo M; Bahamondes L
Contraception; 2008 Jan; 77(1):30-3. PubMed ID: 18082663
[TBL] [Abstract][Full Text] [Related]
10. Vaginal pH and microbiota during fluconazole maintenance treatment for recurrent vulvovaginal candidosis (RVVC).
Donders GG; Grinceviciene S; Ruban K; Bellen G
Diagn Microbiol Infect Dis; 2020 Jun; 97(2):115024. PubMed ID: 32253071
[TBL] [Abstract][Full Text] [Related]
11. Effect of intracervical anesthesia on pain associated with the insertion of the levonorgestrel-releasing intrauterine system in women without previous vaginal delivery: a RCT.
Castro TV; Franceschini SA; Poli-Neto O; Ferriani RA; Silva de Sá MF; Vieira CS
Hum Reprod; 2014 Nov; 29(11):2439-45. PubMed ID: 25240012
[TBL] [Abstract][Full Text] [Related]
12. Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome.
Brooks JP; Edwards DJ; Blithe DL; Fettweis JM; Serrano MG; Sheth NU; Strauss JF; Buck GA; Jefferson KK
Contraception; 2017 Apr; 95(4):405-413. PubMed ID: 27913230
[TBL] [Abstract][Full Text] [Related]
13. Liquid-based cervical cytology and microbiological analyses in women using cooper intrauterine device and levonorgestrel-releasing intrauterine system.
Eleuterio J; Giraldo PC; Silveira Gonçalves AK; Nunes Eleuterio RM
Eur J Obstet Gynecol Reprod Biol; 2020 Dec; 255():20-24. PubMed ID: 33065517
[TBL] [Abstract][Full Text] [Related]
14. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Chin J; Konje JC; Hickey M
Cochrane Database Syst Rev; 2009 Oct; (4):CD007245. PubMed ID: 19821400
[TBL] [Abstract][Full Text] [Related]
15. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
[TBL] [Abstract][Full Text] [Related]
16. Pain and bleeding pattern related to levonorgestrel intrauterine system (LNG-IUS) insertion.
Van Schoubroeck D; Van den Bosch T; Ameye L; Veldman J; Hindryckx A; Werbrouck E; Timmerman D
Eur J Obstet Gynecol Reprod Biol; 2013 Nov; 171(1):154-6. PubMed ID: 24029596
[TBL] [Abstract][Full Text] [Related]
17. Abnormal vaginal microbioma is associated with severity of localized provoked vulvodynia. Role of aerobic vaginitis and Candida in the pathogenesis of vulvodynia.
Donders GGG; Bellen G; Ruban KS
Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1679-1685. PubMed ID: 29934834
[TBL] [Abstract][Full Text] [Related]
18. Two Years Follow-Up of Patients with Abnormal Uterine Bleeding after Insertion of the Levonorgestrel-Releasing Intrauterine System.
Cim N; Soysal S; Sayan S; Yildizhan B; Karaman E; Cetin O; Tolunay HE; Yildizhan R
Gynecol Obstet Invest; 2018; 83(6):569-575. PubMed ID: 29223999
[TBL] [Abstract][Full Text] [Related]
19. Levonorgestrel-Releasing Intrauterine System for Women With Polycystic Ovary Syndrome: Metabolic and Clinical Effects.
da Silva AV; de Melo AS; Barboza RP; de Paula Martins W; Ferriani RA; Vieira CS
Reprod Sci; 2016 Jul; 23(7):877-84. PubMed ID: 26733500
[TBL] [Abstract][Full Text] [Related]
20. Endothelial function in women using levonorgestrel-releasing intrauterine system (LNG-IUS).
Selim MF; Hussein AF
Contraception; 2013 Apr; 87(4):396-403. PubMed ID: 23332246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]